Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Phosbind Acrylamide: Precision Tools for Dynamic Phosphoryla
2026-06-04
Explore how Phosbind Acrylamide empowers advanced protein phosphorylation analysis using antibody-free SDS-PAGE. This article uniquely bridges mechanistic insights and assay optimization, offering researchers a deeper understanding of phosphate-binding reagents in complex signaling studies.
-
Transcription Condensate Dynamics Safeguard Genome Stability
2026-06-04
Marmolejo et al. uncover how transcription condensates at histone locus bodies are precisely regulated during S phase to balance linker histone expression with DNA replication. This mechanistic insight reveals a kinase-governed switch that maintains genome integrity, with implications for understanding transcription-replication coordination in proliferating cells.
-
MLKL Polymerization Triggers Lysosomal Permeabilization in N
2026-06-03
The referenced study uncovers how MLKL polymerization on lysosomal membranes induces their permeabilization, releasing cathepsins that drive necroptotic cell death. This mechanistic insight reshapes our understanding of regulated necrosis and highlights cathepsin B as a key intervention point for modulating necroptosis in disease contexts.
-
Mechanisms of Hepatocellular Death and Relevance in Liver Di
2026-06-03
This review by Luedde et al. systematically examines the distinct mechanisms of hepatocyte death—apoptosis, necrosis, and necroptosis—and their specific roles in the progression of acute and chronic liver diseases. The paper emphasizes the clinical impact of these pathways, highlighting their diagnostic, prognostic, and therapeutic relevance, and outlines how disruption in cell death responses shapes fibrosis, cirrhosis, and hepatocellular carcinoma.
-
Simvastatin Induces Autophagy and Inhibits Prostate Cancer C
2026-06-02
This study demonstrates that simvastatin induces autophagy and inhibits proliferation across several prostate cancer cell lines. The research reveals a concentration-dependent effect and highlights the potential of combining simvastatin with rapamycin to enhance autophagy and anti-proliferative activity, offering mechanistic insight for future therapeutic exploration.
-
Annexin V, Human Recombinant: Precision Phosphatidylserine B
2026-06-02
Annexin V, human recombinant, is a high-affinity phosphatidylserine binding protein essential for early apoptosis detection. Its calcium-dependent interaction with externalized PS enables sensitive, reproducible apoptosis assays. The reagent’s reliability and flexibility make it a gold-standard tool for cell death research and immune cell studies.
-
Primaquine Inhibits Ferroptosis via GSTA1 to Protect Retinal
2026-06-01
This study identifies primaquine as a novel inhibitor of ferroptosis, demonstrating its ability to protect retinal neurons from ischemia/reperfusion (I/R) injury by upregulating GSTA1 activity. The findings highlight a mechanistic link between primaquine, GSTA1, and ferroptosis regulation, offering new directions for neuroprotection in ocular diseases.
-
KPT-330 (Selinexor): Applied CRM1 Inhibition in Cancer Model
2026-06-01
KPT-330 (Selinexor) empowers researchers to dissect nuclear export mechanisms and drive apoptosis induction in resistant malignancies. This article details robust workflows, innovative use-cases, and troubleshooting strategies for leveraging this selective CRM1 inhibitor across cancer research applications.
-
CDC42 Regulates HBV Entry via NTCP Trafficking and Macropino
2026-05-31
This study uncovers how CDC42, a Rho GTPase, facilitates hepatitis B virus (HBV) entry by directing NTCP translocation to the plasma membrane and enabling macropinocytosis. These mechanistic insights refine our understanding of HBV infection and highlight CDC42 as a potential antiviral target.
-
Thiazovivin (A5506): ROCK Inhibitor Protocols for Stem Cell
2026-05-30
Thiazovivin is a high-purity ROCK inhibitor that directly addresses cell survival and reprogramming bottlenecks in stem cell research workflows. It is best used to enhance human embryonic stem cell survival post-dissociation and to increase the efficiency of induced pluripotent stem cell generation. Thiazovivin should not be used for diagnostic or therapeutic purposes outside of laboratory research.
-
Targeted SPP1 Inhibition in Tumor-Associated Macrophages
2026-05-29
This study introduces a novel strategy for reducing SPP1 expression in tumor-associated macrophages (TAMs) using a phenotypic screen and nanoformulation of small molecule inhibitors. The approach effectively decreases tumor size in preclinical models, with implications for developing new macrophage-directed cancer therapies.
-
Rapakinin Induces Vasorelaxation via PGI2–IP and CCK1 Pathwa
2026-05-29
The referenced study elucidates that rapakinin, a peptide from rapeseed protein, induces endothelium-dependent vasorelaxation in hypertensive rat arteries primarily through prostaglandin I2–IP receptor and downstream CCK1 receptor signaling, rather than nitric oxide pathways. This mechanistic distinction advances our understanding of alternative targets for vascular tone regulation and hypertension therapy.
-
Vidarabine Monohydrate: Reliable Antiviral for Laboratory As
2026-05-28
This article addresses key laboratory challenges in cell-based antiviral and cytotoxicity assays, demonstrating how Vidarabine monohydrate (SKU C6377) from APExBIO provides reproducible, high-purity solutions. By exploring real-world scenarios, the piece guides researchers in optimizing assay design, compound handling, and vendor selection for robust inhibition of viral DNA synthesis.
-
Practical Guide: Hoechst 33342/PI Double Staining Kit (K2237
2026-05-28
The Hoechst 33342/PI Double Staining Kit enables fluorescence-based distinction of viable, apoptotic, and necrotic cells by simultaneously assessing chromatin condensation and membrane integrity. It is intended for basic research workflows in cell death analysis and is not suitable for diagnostic or medical use.
-
Staurosporine: Broad-Spectrum Kinase Inhibitor for Cancer As
2026-05-27
Staurosporine enables robust, reproducible analysis of kinase signaling and apoptosis induction in cancer research, especially for dissecting metastatic mechanisms. Its broad-spectrum inhibition profile and proven anti-angiogenic capabilities make it a gold standard for both routine and advanced workflows.